Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
As bird flu swept through Europe in 2023, the U.S. enacted import bans. In October 2023, France became the first major ...
The study included vaccine candidates against H5 and H7 avian influenza viruses. Based on the positive preliminary data from the Phase 1/2 study, Moderna is preparing to advance mRNA-1018 into ...
CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback